Insights

Growing Market Presence Amicus Therapeutics has expanded its global footprint across over 20 countries and actively participates in major industry conferences such as the J.P. Morgan Healthcare Conference and the Bank of America Healthcare Conference, indicating increased visibility and potential for strategic partnerships.

Innovative Product Launches The successful global launch of therapies like Galafold and Pombilion demonstrates strong market reception and offers opportunities to sell complementary products, manufacturing services, or support solutions to facilitate further product development and commercialization.

Strategic Collaborations Partnerships such as the recent agreement with Dimerix Limited for FSGS treatment highlight opportunities to offer contract research, clinical trial services, or bioscience partnerships to support Amicus’s ongoing development pipeline.

Robust Financial Engagement Amicus has secured significant funding and investments, including a strategic $30 million investment from Blackstone, presenting opportunities for financial services, investor relations, and advanced analytics solutions to assist in scaling operations and research activities.

Focus on Rare Diseases Specializing in rare metabolic diseases with patient-centric, innovative solutions positions Amicus to be receptive to services in specialty manufacturing, supply chain management, and personalized healthcare offerings tailored to niche markets.

Amicus Therapeutics Tech Stack

Amicus Therapeutics uses 8 technology products and services including OneTrust, NetSuite, Microsoft 365, and more. Explore Amicus Therapeutics's tech stack below.

  • OneTrust
    Cookie Compliance
  • NetSuite
    E-commerce
  • Microsoft 365
    Email
  • Microsoft Outlook
    Email
  • Google Fonts API
    Font Scripts
  • Web Vitals
    Javascript Libraries
  • Vimeo
    Video Players
  • Facebook
    Widgets

Media & News

Amicus Therapeutics's Email Address Formats

Amicus Therapeutics uses at least 2 format(s):
Amicus Therapeutics Email FormatsExamplePercentage
FLast@amicusrx.comJDoe@amicusrx.com
98%
FMiddleLast@amicusrx.comJMichaelDoe@amicusrx.com
1%
FirstLast@amicusrx.comJohnDoe@amicusrx.com
1%
FLast@amicustherapeutics.comJDoe@amicustherapeutics.com
98%
Last@amicustherapeutics.comDoe@amicustherapeutics.com
1%
Last_First@amicustherapeutics.comDoe_John@amicustherapeutics.com
1%

Frequently Asked Questions

What is Amicus Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Amicus Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amicus Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Amicus Therapeutics is a publicly traded company; the company's stock symbol is FOLD.

What is Amicus Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Amicus Therapeutics's official website is amicusrx.com and has social profiles on LinkedInCrunchbase.

How much revenue does Amicus Therapeutics generate?

Minus sign iconPlus sign icon
As of December 2025, Amicus Therapeutics's annual revenue is estimated to be $5B.

What is Amicus Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Amicus Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Amicus Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Amicus Therapeutics has approximately 608 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief People Officer: D. C.Chief Patient Officer: T. P.Chief Science Officer: J. W.. Explore Amicus Therapeutics's employee directory with LeadIQ.

What industry does Amicus Therapeutics belong to?

Minus sign iconPlus sign icon
Amicus Therapeutics operates in the Biotechnology Research industry.

What technology does Amicus Therapeutics use?

Minus sign iconPlus sign icon
Amicus Therapeutics's tech stack includes OneTrustNetSuiteMicrosoft 365Microsoft OutlookGoogle Fonts APIWeb VitalsVimeoFacebook.

What is Amicus Therapeutics's email format?

Minus sign iconPlus sign icon
Amicus Therapeutics's email format typically follows the pattern of FLast@amicusrx.com. Find more Amicus Therapeutics email formats with LeadIQ.

How much funding has Amicus Therapeutics raised to date?

Minus sign iconPlus sign icon
As of December 2025, Amicus Therapeutics has raised $30M in funding. The last funding round occurred on Oct 02, 2023 for $30M.

When was Amicus Therapeutics founded?

Minus sign iconPlus sign icon
Amicus Therapeutics was founded in 2002.

Amicus Therapeutics

Biotechnology ResearchNew Jersey, United States501-1000 Employees

We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. 

Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture and influences all aspects of our approach to advancing cutting-edge technologies.

Building on our core beliefs, our mission-focused behaviors help us define and shape our culture; drive performance and innovation; inform development and growth; and attract, energize, and retain the right talent. By championing mission-dedication, innovation, performance, and integrity, we are united by our passion for making a difference and committed to pushing ideas as far and as fast as possible.

Our global footprint spans over 20 countries, including our global headquarters in Princeton, NJ and international headquarters in Marlow, UK. Additional international office locations include Australia, Canada, France, Japan, Germany, Italy, The Netherlands, and Spain. More information about Amicus and our career opportunities can be found at www.amicusrx.com.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
FOLD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2002
Employees
501-1000

Section iconFunding & Financials

  • $30M

    Amicus Therapeutics has raised a total of $30M of funding over 20 rounds. Their latest funding round was raised on Oct 02, 2023 in the amount of $30M.

  • $250M$500M

    Amicus Therapeutics's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $30M

    Amicus Therapeutics has raised a total of $30M of funding over 20 rounds. Their latest funding round was raised on Oct 02, 2023 in the amount of $30M.

  • $250M$500M

    Amicus Therapeutics's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.